2O9A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Renalytix PLC

Watchlist Manager

Watchlist

Price: 0.1625 EUR Market Closed

Market Cap: €15.4m

	Renalytix PLC F:2O9A	UK
	Triplepoint Venture Growth BDC Corp NYSE:TPVG	US
C	Ceres Power Holdings PLC OTC:CRPHY	UK
A	Ayvens SA OTC:ALLDF	FR
	Sumitomo Pharma Co Ltd OTC:SMDPY	JP
	Apartment Investment and Management Co F:AIV	US
S	Sumitomo Pharma Co Ltd SWB:DPM	JP
L	Linamar Corp F:LNR	CA
I	IDT Corp XMUN:IDC2	US

Profitability Summary

Renalytix PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

45%

Sustainable 3Y Average Gross Margin

24%

Gross Margin is Increasing

30% > 45%

Negative Operating Margin

-501%

Negative 3Y Average Operating Margin

-1.090%

Operating Margin is Increasing

-1.378% > -501%

Negative Net Margin

-594%

Negative 3Y Average Net Margin

-1.312%

Net Margin is Increasing

-1.492% > -594%

Negative Free Cash Flow Margin

-393%

Negative 3Y Average Free Cash Flow Margin

-947%

Free Cash Flow Margin is Increasing

-956% > -393%

Exceptional ROE

475%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-138%

ROIC is Increasing

-652% > -364%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.